Shukra Pharmaceuticals Ltd — Important, 12-09-2025: Company Update

Shukra Pharmaceuticals has issued a corrigendum to its 32nd Annual General Meeting notice and Annual Report for FY2024-25. The company has corrected a typographical error concerning the Record Date for dividend entitlement. Shareholders should note that the updated Record Date for determining eligibility for the financial year ended March 31, 2025, is now Thursday, September 18, 2025. This revision is crucial for investors tracking dividend eligibility.